• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Alnylam Pharmaceuticals Inc.

Headquarters: Cambridge, MA, United States
Year Founded: 2002
Status: Public
Industry Sector: HealthTechnology
CEO: Yvonne L. Greenstreet, MD, MBA
Number Of Employees: 2,230
Enterprise Value: $30,086,471,810
PE Ratio: -127.84
Exchange/Ticker 1: NASDAQ:ALNY
Exchange/Ticker 2: N/A
Latest Market Cap: $34,795,339,776